Co-Administration of Molecular Adjuvants Expressing NF-Kappa B Subunit p65/RelA or Type-1 Transactivator T-bet Enhance Antigen Specific DNA Vaccine-Induced Immunity

By Shedlock Devon J.   Tingey Colleen   Mahadevan Lavanya   Hutnick Natalie   Reuschel Emma L.   Kudchodkar Sagar   Flingai Seleeke   Yan Jenny   Kim Joseph J.   Ugen Kenneth E.   Weiner David B.   Muthumani Kar  

Vaccines, Vol. 2, Iss. 2, 2014-03 ,pp. : 196-215

MDPI

Access to resources Recommend Favorite

Co-Administration of Lipid Nanoparticles and Sub-Unit Vaccine Antigens Is Required for Increase in Antigen-Specific Immune Responses in Mice

By Thoryk Elizabeth A.   Swaminathan Gokul   Meschino Steven   Cox Kara S.   Gindy Marian   Casimiro Danilo R.   Bett Andrew J.  

Vaccines, Vol. 4, Iss. 4, 2016-12 ,pp. : 47-47

MDPI

Access to resources Recommend Favorite

Electrotransfer of Plasmid DNA Encoding an Anti-Mouse Endoglin (CD105) shRNA to B16 Melanoma Tumors with Low and High Metastatic Potential Results in Pronounced Anti-Tumor Effects

By Dolinsek Tanja   Sersa Gregor   Prosen Lara   Bosnjak Masa   Stimac Monika   Razborsek Urska   Cemazar Maja  

Cancers, Vol. 8, Iss. 1, 2015-12 ,pp. : 3-3

MDPI

Access to resources Recommend Favorite

Novel Antitumor Strategy Utilizing a Plasmid Expressing a Mycobacterium tuberculosis Antigen as a “Danger Signal” to Block Immune Escape of Tumor Cells

By Koyama Yoshiyuki   Yoshihara Chieko   Ito Tomoko  

Pharmaceutics, Vol. 7, Iss. 3, 2015-07 ,pp. : 165-174

MDPI

Access to resources Recommend Favorite

Nonclinical Development of BCG Replacement Vaccine Candidates

By Velmurugan Kamalakannan   Grode Leander   Chang Rosemary   Fitzpatrick Megan   Laddy Dominick   Hokey David   Derrick Steven   Morris Sheldon   McCown David   Kidd Reginald   Gengenbacher Martin   Eisele Bernd   Kaufmann Stefan H.E.   Fulkerson John   Brennan Michael J.  

Vaccines, Vol. 1, Iss. 2, 2013-04 ,pp. : 120-138

MDPI

Access to resources Recommend Favorite